Chlorambucil-Bearing Hybrid Molecules in the Development of Potential Anticancer Agents
Increasing cases of cancer have been a primary concern in recent decades. Developing new chemotherapeutics is challenging and has been faced with limitations, such as multidrug resistance, poor specificity, selectivity, and toxicity. The aforementioned factors contribute to treatment failure. Hybrid...
Main Authors: | Sijongesonke Peter, Blessing Atim Aderibigbe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/19/6889 |
Similar Items
-
Doxorubicin-Based Hybrid Compounds as Potential Anticancer Agents: A Review
by: Sijongesonke Peter, et al.
Published: (2022-07-01) -
Discovery of a potent olaparib–chlorambucil hybrid inhibitor of PARP1 for the treatment of cancer
by: Hongyu Qin, et al.
Published: (2023-01-01) -
Biochemical and pathological studies on the effects of levamisole and chlorambucil on Ehrlich ascites carcinoma-bearing mice
by: Fakhry S. Salem, et al.
Published: (2011-01-01) -
Long-term management of a cat with nasopharyngeal lymphoma by chlorambucil
by: Kaho Takahashi, et al.
Published: (2021-04-01) -
Chlorambucil-Loaded Graphene-Oxide-Based Nano-Vesicles for Cancer Therapy
by: Surabhi Kumari, et al.
Published: (2023-02-01)